Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,812 | 651 | 99.8% |
| Education | $15.64 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,237 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,207 | 78 | $0 (2024) |
| Lilly USA, LLC | $855.56 | 58 | $0 (2024) |
| Novo Nordisk Inc | $757.24 | 42 | $0 (2024) |
| PFIZER INC. | $735.24 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $659.68 | 45 | $0 (2024) |
| ABBVIE INC. | $641.25 | 60 | $0 (2024) |
| Merck Sharp & Dohme LLC | $517.28 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $486.31 | 44 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $361.91 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,753 | 101 | AstraZeneca Pharmaceuticals LP ($459.91) |
| 2023 | $1,700 | 101 | Novo Nordisk Inc ($270.42) |
| 2022 | $1,336 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($222.13) |
| 2021 | $537.01 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($163.35) |
| 2020 | $461.59 | 26 | Boston Scientific Corporation ($116.27) |
| 2019 | $1,581 | 110 | AstraZeneca Pharmaceuticals LP ($282.23) |
| 2018 | $881.36 | 68 | AstraZeneca Pharmaceuticals LP ($152.11) |
| 2017 | $1,578 | 123 | Boehringer Ingelheim Pharmaceuticals, Inc. ($297.54) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $35.04 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Vaccines | ||||||
| 10/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Obesity | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: VACCINES | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: PAIN | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,070 | 1,418 | $337,515 | $106,957 |
| 2022 | 18 | 1,100 | 1,407 | $315,448 | $97,201 |
| 2021 | 20 | 1,378 | 1,846 | $256,791 | $137,736 |
| 2020 | 22 | 1,307 | 1,839 | $237,081 | $117,487 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 497 | $159,537 | $45,458 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 269 | $58,642 | $18,080 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $50,099 | $16,922 | 33.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 32 | 32 | $14,880 | $8,472 | 56.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 24 | $20,016 | $5,639 | 28.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 59 | 59 | $10,030 | $4,234 | 42.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 36 | 36 | $10,692 | $2,682 | 25.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 69 | $2,070 | $2,029 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 74 | 74 | $4,884 | $1,499 | 30.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $930.00 | $882.00 | 94.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 117 | 121 | $3,025 | $453.44 | 15.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 35 | 37 | $2,294 | $411.52 | 17.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 33 | 33 | $297.00 | $137.28 | 46.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 17 | $119.00 | $57.97 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 401 | $128,721 | $36,276 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 271 | $59,078 | $18,326 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $42,100 | $14,483 | 34.4% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 23 | 23 | $19,504 | $5,596 | 28.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 46 | 46 | $13,662 | $3,815 | 27.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 15 | $12,510 | $3,740 | 29.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 49 | 49 | $8,330 | $3,358 | 40.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 123 | 123 | $8,118 | $2,611 | 32.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 11 | $6,490 | $2,139 | 33.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $5,145 | $1,986 | 38.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $1,740 | $1,705 | 98.0% |
About Dr. Christopher Horn, D.O
Dr. Christopher Horn, D.O is a Family Medicine healthcare provider based in Rockaway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821095605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Horn, D.O has received a total of $9,828 in payments from pharmaceutical and medical device companies, with $1,753 received in 2024. These payments were reported across 654 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,812).
As a Medicare-enrolled provider, Horn has provided services to 4,855 Medicare beneficiaries, totaling 6,510 services with total Medicare billing of $459,380. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Rockaway, NJ
- Active Since 07/07/2005
- Last Updated 12/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821095605
Products in Payments
- JARDIANCE (Drug) $1,168
- FARXIGA (Drug) $700.56
- VRAYLAR (Drug) $440.37
- REXULTI (Drug) $361.91
- BREZTRI (Drug) $343.42
- ANORO (Drug) $292.49
- TRELEGY ELLIPTA (Drug) $286.66
- JANUVIA (Drug) $262.17
- PREVNAR 20 (Biological) $246.05
- Wegovy (Drug) $239.58
- TRADJENTA (Drug) $232.13
- Ozempic (Drug) $220.80
- Trintellix (Drug) $202.25
- INVOKANA (Drug) $201.10
- CHANTIX (Drug) $199.72
- UBRELVY (Drug) $177.39
- XARELTO (Drug) $164.43
- TRULICITY (Drug) $156.54
- NURTEC ODT (Drug) $150.66
- STIOLTO RESPIMAT (Drug) $144.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockaway
Christopher Heitzman, D.o, D.O
Family Medicine — Payments: $1,924
Dr. Olympia Sophias, D.o, D.O
Family Medicine — Payments: $467.89
Dr. Aadya Sharma, Md, MD
Family Medicine — Payments: $289.80
Dr. Oluwatoyin Fapohunda-Adekola, Md, MD
Family Medicine — Payments: $190.96
Dr. Ian Brodrick, M.d, M.D
Family Medicine — Payments: $145.14
Christine Sedlacek, Md, MD
Family Medicine — Payments: $104.64